Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214201
Status:
COMPLETED
Last Update Posted:
2012-10-03
First Post:
2005-09-13
Brief Title:
Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether Campath-1H induction therapy and the associated lymphocyte depletion will permit long-term rejection free renal allograft function in the absence of maintenance calcineurin inhibitor CI therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None